Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
11.42
-0.33 (-2.81%)
At close: Sep 28, 2026, 4:00 PM EDT
11.49
+0.07 (0.61%)
Pre-market: Sep 29, 2026, 7:47 AM EDT
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $1.6 billion as of September 28, 2026. Its market cap has decreased by -8.60% in one year.
Market Cap
1.60B
Enterprise Value
1.05B
1-Year Change
-8.60%
Ranking
Category
Stock Price
$11.42
ChartMarket Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $1.60B, an increase of 111.25%. That is a compound annual growth rate of 7.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 1.60B | 53.67% |
| Dec 31, 2025 | 1.04B | -12.32% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
| May 6, 2016 | 757.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Septerna | 1.76B |
| Zenas BioPharma | 1.76B |
| Novavax | 1.75B |
| Nanobiotix | 1.69B |
| Absci | 1.67B |
| GH Research | 1.64B |
| Rapport Therapeutics | 1.63B |
| Syndax Pharmaceuticals | 1.63B |